Bemarituzumab (Anti-FGFR2 / CD332)Bemarituzumab (Anti-FGFR2 / CD332)
Move your mouse over image or click to enlarge

Bemarituzumab (Anti-FGFR2 / CD332)

Bemarituzumab (Anti-FGFR2 / CD332) is a first-in-class, humanized IgG1 monoclonal antibody against FGFR2b (a FGF receptor). Bemarituzumab blocks fibroblast growth factors from binding and activating FGFR2b. Bemarituzumab has the potential for cancer research. MW: 145.24 KD.
Cat# Size Price Qty Buy
A2497-1mg*25 1mg*25
£1,941.00
A2497-1mg*5 1mg*5
£647.00
A2497-1mg 1mg
£221.00

Additional Information

Property Value or Rating
Manufacturer Selleck Chemicals LLC
Manufacturer Cat# A2497

Related Documents